Short-chain fatty acid levels in stools of patients with inflammatory bowel disease are lower than those in healthy subjects

• Published in: European journal of gastroenterology & hepatology Vol. 36; no. 7; p. 890
• Main Authors: Ozturk, Ozlem, Celebi, Gurkan, Duman, Umut Goktan, Kupcuk, Erhan, Uyanik, Metin, Sertoglu, Erdim
• Format: Journal Article
• Language: English
• Published: England 01.07.2024
• Subjects: Acetic Acid - analysis; Acetic Acid - metabolism; Adult; Butyric Acid - analysis; Butyric Acid - metabolism; Case-Control Studies; Colitis, Ulcerative - metabolism; Colitis, Ulcerative - microbiology; Crohn Disease - metabolism; Diet; Fatty Acids, Volatile - analysis; Fatty Acids, Volatile - metabolism; Feces - chemistry; Feces - microbiology; Female; Gas Chromatography-Mass Spectrometry; Gastrointestinal Microbiome; Humans; Male; Middle Aged; Propionates - analysis; Propionates - metabolism; Young Adult
• DOI: 10.1097/MEG.0000000000002789

Short-chain fatty acids (SCFAs) are produced when the microbiota in the large intestine cause fermentation of dietary carbohydrates and fibers. These fatty acids constitute the primary energy source of colon mucosa cells and have a protective effect in patients suffering from inflammatory bowel disease (IBD). This study aimed to compare the SCFA levels in the stools of patients with IBD and healthy controls. Healthy controls and patients with IBD aged 18 and over were included in the study. Stool samples from all patients and healthy controls were collected, and stool acetic acid, propionic acid, and butyric acid levels were measured using a gas chromatography-mass spectrometry measurement method. In this study, 64 participants were divided into two groups: 34 were in IBD (Crohn disease and ulcerative colitis) and 30 were in healthy control group. When fecal SCFA concentrations of IBD and healthy control groups were compared, a statistically significant difference was observed between them. When the fecal SCFA concentrations of Crohn's disease and ulcerative colitis patients in the IBD group were compared, however, no statistically significant difference was observed between them. Furthermore, when the participants' diet type (carbohydrate-based, vegetable-protein-based and mixed diet) and the number of meals were compared with fecal SCFA concentrations, no statistically significant difference was observed between them. In general, fecal SCFA levels in patients with IBD were lower than those in healthy controls. Moreover, diet type and the number of meals had no effect on stool SCFA levels in patients with IBD and healthy individuals.